GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HCV NS3/4A protease in complex with voxilaprevir

Analyse Crystal structure of HCV NS3/4A protease in complex with voxilaprevir in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6NZT
Type
protein
Length
191 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HCV NS3/4A protease
UniProt
S4UY05
Ligands
L9P, ZN, SO4
Pockets
2 · best druggability 0.39

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHCV NS3/4A proteaseprotein19114% helix, 46% strandS4UY05

Ligands and binding sites

  • L9P · Voxilaprevir · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1520.390.8115empty
2530.290.7515empty

Compared structures

  • 6NZT · Crystal structure of HCV NS3/4A protease in complex with voxilaprevir · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.